HC Wainwright Issues Optimistic Forecast for SGMO Earnings
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Investment analysts at HC Wainwright lifted their Q3 2025 EPS estimates for shares of Sangamo Therapeutics in a report issued on Wednesday, May 14th. HC Wainwright analyst P. Trucchio now anticipates that the biopharmaceutical company will post earnings of ($0.08) per share for the quarter, up from […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Investment analysts at HC Wainwright lifted their Q3 2025 EPS estimates for shares of Sangamo Therapeutics in a report issued on Wednesday, May 14th. HC Wainwright analyst P. Trucchio now anticipates that the biopharmaceutical company will post earnings of ($0.08) per share for the quarter, up from […]
